Skip to contentL
Lexicon Pharmaceuticals, Inc.
L
LXRXLexicon Pharmaceuticals, Inc. Q1 2016 · 10-Q
Revenue$17.96M$17.96M+43.8% vs Q1 2015 Net Income-$34.89M-$34.89MN/M vs Q1 2015 EPS Diluted-$0.31-$0.31N/M vs Q1 2015 Operating Income-$42,485,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
Free Cash Flowderived-$85,588,000N/M Margins · derivedOperating margin-236.5%+34.6 pt vs Q1 2015
Net margin-194.2%+84.9 pt vs Q1 2015
ended Mar 31, 2017 · filed May 4, 2017 · 34 d after period end